Skip to content
ppharmaranks
Menu

Best treatments for malignant mesothelioma

4 products may treat malignant mesothelioma, spanning FDA drug classes such as programmed death receptor-1 blocking antibody. The current highest-rated option is keytruda. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for malignant mesothelioma, none are yet flagged as generics in our price data, spanning classes such as programmed death receptor-1 blocking antibody. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for malignant mesothelioma — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Top-rated picks for malignant mesothelioma: 1. Keytruda · 2. Pemfexy · 3. Axtle

Top-rated treatments for malignant mesothelioma, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
270/100View →
3Not yet ratedView →
4Not yet ratedView →

Full ranking · 4 treatments

Frequently asked

What treats malignant mesothelioma?
Our catalog lists 4 products that may treat malignant mesothelioma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is keytruda.
What is the best-rated treatment for malignant mesothelioma?
By our independent recall-safety rating — not an efficacy measure — keytruda ranks highest among the products we list for malignant mesothelioma. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat malignant mesothelioma?
Treatments for malignant mesothelioma span FDA drug classes including programmed death receptor-1 blocking antibody. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.